Literature DB >> 8032947

Effects of chronic treatment with (+)- and (-)-nicotine on nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors in rat brain.

X Zhang1, Z H Gong, A Nordberg.   

Abstract

In this study, the effects of chronic treatment with (+)-nicotine on brain nicotinic acetylcholine receptors (nAChRs) and N-methyl-D-aspartate (NMDA) receptors, as well as on animal body weight were compared with those of chronic treatment with (-)-nicotine. Male Sprague-Dawley rats were s.c. injected with saline, (+)-nicotine (2.0 mg free base/kg b.w.) or (-)-nicotine (0.45 mg free base/kg b.w.) for 18 days. Brain nAChRs were investigated by (-)-[3H]nicotine binding. A significant increase in the high-affinity (-)-[3H]nicotine (5 nM)-binding sites was observed in the cortex, hippocampus, midbrain and striatum but not in the cerebellum of the rats treated with either (+)- or (-)-nicotine. The displacement curves of (-)-[3H]nicotine/(-)-nicotine in the cortices of rats treated with either (+)- or (-)-nicotine showed only one population of high-affinity binding sites, whereas both high- and low-affinity binding sites were observed in the cortices of control animals. Brain NMDA receptors were studied by [3H]MK-801, which binds to the NMDA receptor-ion channel complex. A significant decrease in the Bmax, but not in the KD for [3H]MK-801 binding in the cortices of rats treated with either (+)- or (-)-nicotine was only detected under certain experimental conditions where the NMDA receptors seem not to be maximally activated. The body weight of the animals treated with (-)-nicotine was significantly lower than that of the control animals, whereas there was no difference in body weight between (+)-nicotine- and saline-treated animals.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032947     DOI: 10.1016/0006-8993(94)90343-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Chronic nicotine alters nicotinic receptor-induced presynaptic Ca2+ responses in isolated nerve terminals.

Authors:  John J Dougherty; Jianlin Wu; Tejal K Mehta; Brett Brown; Robert A Nichols
Journal:  Neurochem Res       Date:  2007-12-20       Impact factor: 3.996

2.  Effects of chronic neonatal nicotine exposure on nicotinic acetylcholine receptor binding, cell death and morphology in hippocampus and cerebellum.

Authors:  L Z Huang; L C Abbott; U H Winzer-Serhan
Journal:  Neuroscience       Date:  2007-04-16       Impact factor: 3.590

3.  Changes in the glutamate release and uptake of cerebellar cells in perinatally nicotine-exposed rat pups.

Authors:  D K Lim; H S Kim
Journal:  Neurochem Res       Date:  2001-10       Impact factor: 3.996

4.  Synthetic nicotine has arrived.

Authors:  Sven-Eric Jordt
Journal:  Tob Control       Date:  2021-09-07       Impact factor: 7.552

5.  Tobacco smoke exposure induces nicotine dependence in rats.

Authors:  Elysia Small; Hina P Shah; Jake J Davenport; Jacqueline E Geier; Kate R Yavarovich; Hidetaka Yamada; Sreedharan N Sabarinath; Hartmut Derendorf; James R Pauly; Mark S Gold; Adrie W Bruijnzeel
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

6.  Impact of sustained exposure to β-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptors.

Authors:  Komal Arora; Naghum Alfulaij; Jason K Higa; Jun Panee; Robert A Nichols
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

7.  Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase.

Authors:  Marie M Svedberg; Anne-Lie Svensson; Mary Johnson; Mandy Lee; Osnat Cohen; Jennifer Court; Hermona Soreq; Elaine Perry; Agneta Nordberg
Journal:  J Mol Neurosci       Date:  2002-06       Impact factor: 3.444

Review 8.  Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease.

Authors:  J R James; A Nordberg
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.